pr-inside.com
Print

Impax Laboratories to Present at the Credit Suisse 18th Annual Healthcare Conference



2009-11-10 22:25:05 -

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Credit Suisse 18th Annual Healthcare Conference on Friday, November 13th, at 10:00 a.m.

Mountain Standard time. The conference will be held at the Arizona Biltmore Hotel located in Phoenix, AZ.

Individuals may listen to the live or an archived presentation made at the conferences, which will be

posted in the investor relations section of the Company’s web site at www.impaxlabs.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .

This presentation will be archived on the Company’s web site for 30 days.



About Impax Laboratories, Inc.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .

Impax Laboratories, Inc.Mark

Donohue, Sr. Director Investor Relations215-933-3526 www.impaxlabs.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..

Author:
Hossam Abdel-Kader
e-mail
Web: http://www.pr-inside.com/
Telefon: +43 1 9582319




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.